drugset / Trial / NCT03123107

Vitamin C in Cardiac Surgery Patients

NCT03123107

Phase 1 Completed 6 enrolled Geisinger Clinic Wilkes University · collab
NaSingle-groupOpen-labelBasic science

Summary

Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery that increases the incidence of stroke, kidney injury and death. Vitamin C has been shown to decrease the incidence of POAF follow cardiac surgery, but the optimal dose has not been identified. With this project, the investigators plan to gather pharmacokinetic and dose-response data for vitamin C in the cardiac surgery population. The investigators plan to conduct a small interventional pilot study investigating the pharmacokinetics and pharmacodynamics of Vitamin C in patients undergoing coronary artery bypass graft (CABG) surgery. Patients enrolled will receive an intravenous dose of Vitamin C the day before surgery and the day after. Patients will have blood samples obtained with each dose for analysis of vitamin C concentrations and several biomarkers of oxidative stress. Analysis of samples will be performed within the Department of Pharmaceutical Sciences at Wilkes University.

Timeline

Start
2017-07-06
Primary completion
2019-05-31
Completion
2019-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 15 mg/kg Intravenous
Subject Vitamin C Other / unclassified 30 mg/kg Intravenous

Indications

No indication recorded.